No profile data available.
Catheter Precision, Inc. (VTAK) is a healthcare company in the heart treatment equipment industry, based in Fort Mill, United States, with about 17 full-time employees.
It reported revenue of $819,000 for fiscal year 2025, up 95.0% from fiscal year 2024, and net income of -$17.18 million. United States was its largest region in fiscal year 2025, with 80% of revenue. Its market capitalization was $286,477 as of October 2, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 2, 2026.
Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States and Europe.
Catheter Precision reported $819,000 in revenue for fiscal year 2025, up 95.0% from $420,000 in fiscal year 2024.
United States: 80% of revenue by region in fiscal year 2025, followed by Europe (20%).
$286,477 as of October 2, 2026.
Listed companies of a similar size in the same industry (heart treatment equipment) include Adagio Medical Holdings, Inc. (ADGM), Nuwellis, Inc. (NUWE), Biotricity, Inc. (BTCY), Marizyme, Inc. (MRZM).